Pharmacodynamic (kinetic) considerations in the treatment of moderately sever infections with cefotaxime
- 30 June 1995
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 22 (1) , 57-69
- https://doi.org/10.1016/0732-8893(95)00071-h
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Inoculum EffectClinical Infectious Diseases, 1989
- Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'Antimicrobial Agents and Chemotherapy, 1989
- Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.Diagnostic Microbiology and Infectious Disease, 1989
- Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newbornDiagnostic Microbiology and Infectious Disease, 1989
- Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infectionsAntimicrobial Agents and Chemotherapy, 1984
- Efficacy of continuous versus intermittent administration of penicillin G inStreptococcus pneumoniae pneumonia in normal and immunodeficient ratsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitisJournal of Antimicrobial Chemotherapy, 1984
- Postantibiotic Suppression of Bacterial GrowthClinical Infectious Diseases, 1981
- A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patientsThe American Journal of Medicine, 1979
- The bactericidal action of penicillin on Staphylococcus pyogenesIrish Journal of Medical Science, 1944